NEW YORK (GenomeWeb News) – Specialty diagnostics laboratory Exagen and Medco Research Institute today announced they have begun a pilot program aimed at helping physicians make better dosing decisions for a rheumatoid arthritis medication.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.